Stockreport

Travere Therapeutics to Report First Quarter 2026 Financial Results

Travere Therapeutics, Inc.  (TVTX) 
PDF SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report first quarter 2026 financial results on Monday, May 4, 2026, aft [Read more]